Streetwise Reports' Article Archives — November 2022 back to current month (89)
Target Price Boosted on Canadian Pharma Co. (11/30/2022)
This company, undergoing a business model shift, is doing well and remains Buy rated despite a weaker-than-expected Q3/22, noted a Research Capital Corp. report.
These new data, from three zones at the property, bode well for growing the existing resource there, noted a Haywood Securities report.
HighGold Mining Inc. shares traded 14% higher after the company reported that it intersected 120m of 18.76 g/t gold at its Johnson Tract Deposit in Southcentral Alaska.
Biopharma Co. Now at a Bargain Price, Analyst Says (11/29/2022)
Recent share price weakness and a catalyst-rich next six months are good news for investors, noted a Research Capital Corp. report.
The newly reported drill results also extended the mineralization present at the primary exploration target, noted a Research Capital Corp. report.
Little Drone Co. Could Have Big Impact (11/29/2022)
Volatus Aerospace Corp. could be a company to watch in the fast-growing drone aviation market.
Since hitting the market on November 10, 2022, ASP Isotopes has been busy and has now announced a US$675 million-dollar contract. Expert Penny Queen shares this news and reviews why she still believes this company is worthwhile.
Today, expert Adrian Day sends a revised Current Positions table, updating dividends paid and current recommendations. Prices are as of early afternoon yesterday.
Expert Ron Struthers believes consumers are on an unsustainable path of wracking up credit card debt, and it is only a matter of when the economy buckles, meanwhile big profits are being made by tanker companies and oil and gas/energy transmission companies as supplies continue to tighten.
This company serving the oil and gas industry grew revenue 14% over the last 12 months and is expected to continue the trend, noted an Echelon Capital Markets report.
The Canadian company has already secured two contracts for three-quarters of the capacity of this new pipeline in Colombia, noted a Research Capital Corp. report.
Copper Co. Potentially Expands Deposit in Colombia (11/28/2022)
A soil geochemical anomaly could significantly expand the footprint and potential size of the deposit at Libero Copper and Gold Corp.'s Mocoa project in Putumayo, Colombia.
We're at the Home Stretch (11/28/2022)
With only 33 days left in the fiscal year 2022, expert Michael Ballanger reviews where he believes the markets are heading.
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy.
Biopharma Co. Trades to New 52-Week High (11/28/2022)
Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successfully met both the primary and key secondary endpoints in the Phase 3 ACCORD Alzheimer's disease agitation trial.
BacTech Environmental Corp. is completing an engineering report needed to start construction of its bioleaching plant in Tenguel, Ecuador.
The company aims to achieve record production in Q4/22 to recover from the hit in Q3/22, noted an Echelon Capital Markets report.
The outlook for full-year 2022 production is positive, and growth is expected, noted a Haywood Securities report.
With the breakdown of the U.S. dollar, expert Clive Maund reviews charts for gold, copper, and palladium to tell you where he believes the metals are headed and which he thinks you should buy.
Pharma Co. Gains Approval for SARS-CoV-2 Drug (11/23/2022)
Shares of Japanese pharmaceutical firm Shionogi & Co. Ltd. traded nearly 13% higher yesterday after the company reported it received emergency regulatory approval from Japan's Ministry of Health, Labor, and Welfare for its Xocova® (ensitrelvir fumaric acid) tablets for use in treating SARS-CoV-2 infection.
Mining Royalty Co. Posts Best Cash Margins to Date (11/22/2022)
Also, operating cash flow was a beat during this strong quarter for the Quebec-based firm, noted a Haywood Securities report.
Life Sciences Co. Exceeds Expectations in Q3/22 (11/22/2022)
During the quarter, the Canadian specialty biopharma performed well and maintained a healthy balance sheet, such that it raised revenue guidance for this year, noted a Research Capital Corp. report.
The year's final quarter is significant for this U.S.-based firm given the trio of significant clinical achievements in its sight, noted a Laidlaw & Co. report.
Imago BioSciences Inc. shares traded 104.5% higher yesterday to a new 52-week high after the company reported it entered into a definitive agreement to be acquired by Merck & Co. in an all-cash transaction for US$36.00 per share.
Blockchain Co. Signs Agreement With Insurance Co. (11/22/2022)
Global Compliance Applications Corp. signs an agreement with a South African insurance company to get into that country’s expanding cannabis industry.
Expert Says Silver 'Should Resume Upward Path' (11/22/2022)
Expert Clive Maund reviews silver's 4-month, 1-year, and 5-year charts to tell you where he believes the future is headed for this precious metal.
Tight Lead-Zinc Market Keeping a Floor Under Prices (11/22/2022)
Expert Rick Mills explains the uses, geology, and market for zinc to tell you why he believes this is a transitional metal you should be paying close attention to.
Real Estate REIT Shows Strengthening Fundamentals (11/21/2022)
Growth of net operating income and of net asset value is expected from this investment vehicle in the near and longer term, noted an Echelon Capital Markets report.
Volatus Aerospace Corp.'s acquisition of an Alberta aviation company puts it in a strong position to change the way oil and gas companies monitor their pipelines.
FDA Awards Breakthrough Therapy Status for AMD Drug (11/21/2022)
Iveric Bio Inc. shares traded 25% higher Friday after the company reported that the U.S. FDA has granted breakthrough therapy designation for its avacincaptad pegol for use in the treatment of geographic atrophy secondary to age-related macular degeneration.
Diversification Pays off for Franco Once Again (11/21/2022)
Expert Adrian Day reviews quarterly financials from several resource companies. Most are doing well, though costs are rising. But given recent rallies in stock prices, Day suggests, for the most part, holding rather than buying more.
Expert Says 'No Mas' to Hawkish Fed (11/21/2022)
In light of the controversy with FTX Corp., expert Michael Ballanger shares his opinion on current news coverage and the state of the gold market and U.S. dollar to tell you his view on the precious metals and whether he believes we are headed toward a bear market rally.
Winter Is About To Wake up the Natural Gas Price (11/21/2022)
An unusually warm October has helped natural gas inventories, but gas prices don't seem to believe it. Oil has seen three days of heavy selling volume ending with a hammer candle stick Monday. Birchcliff, Callon, and Earthstone should benefit.
Defense Metals Corp. is looking toward the preliminary feasibility study for its Wicheeda rare earth element deposit in British Columbia.
The explorer's ongoing exploration results at this project continue to be encouraging ahead of a mineral resource update expected next year, noted a Haywood Securities report.
The owner of this Quebec project will include these exploration results in the upcoming definitive feasibility study, noted a Laurentian Bank Securities report.
The U.S. Food and Drug Administration Advisory Panel denied the approval of this therapeutic for patients hospitalized with severe SARS-CoV-2, yet it is still a Buy, noted a Research Capital Corp. report.
Canadian Base Metals Co. Gains Two New Assets (11/17/2022)
The company takeover just closed, and consequently, an NI 43-101 report from the acquirer is expected soon, noted a Research Capital Corp. report.
World Copper's projects in Arizona and Chile are in the near-term development stage.
Shares of Alvopetro Energy Ltd. traded 13% higher yesterday after the company reported record Q3/22 sales, raised its quarterly dividend by 50%, and announced plans for a robust NCIB share buyback program.
Rover Metals Corp. has signed the definitive agreement to option a 100% ownership interest in a Nevada lithium project that puts it closer to its goal of pivoting from gold to lithium and critical elements.
Biopharma Co. Hopes To Turn US$30M Into US$2B (11/17/2022)
CytomX Therapeutics Inc. shares traded 32% higher after the company reported it has formed a strategic research collaboration with Regeneron Pharmaceuticals Inc. to develop next-generation bispecific immunotherapies to treat multiple cancer tumor types.
Target Price Raised on Counterdrone Tech Co. (11/16/2022)
The Australian firm warrants this change given its recent track record in growing revenue, noted a Bell Potter report.
Jericho Energy Ventures Inc., which is making the move to green energy, is selling some of its undeveloped acreage in the STACK oil region of Oklahoma.
4D Molecular Therapeutics Inc. shares traded 38.5% higher yesterday after the company reported interim data from its Phase 1/2 clinical trial of Intravitreal 4D-150 for use in the treatment of wet age-related macular degeneration.
This U.K. healthcare company revealed a compound that's 3.5x more effective in treating alcohol use disorder than the industry standard. Now, expansion is on the horizon.
Lithium Triangle Explorer 'A Smart Money Play' (11/14/2022)
New extraction technology is a game-changer for Spey Resources, which just signed a lithium offtake letter of intent.
Copper Project Returns 'Very Good' Drill Results (11/14/2022)
This data set "highlights the potential of the southern starter pit and its ability to provide higher grade material for longer in the early years of the mine," noted a Research Capital Corp. report.
These early results of 2022 drilling at this Golden Triangle property highlight the presence of high silver grades and potential for future resource growth, noted a Haywood Securities report.
The acquisition is a 0.6% net smelter return royalty on production that is estimated to start at this copper-gold property in late 2029, noted a Haywood Securities report.
The Narcotic Effect of the Reflexive Rebound (11/14/2022)
Expert Michael Ballanger of GGM Advisory Inc. reviews the newest dubbed "investment guru," the outlook of the precious metals sector, and the current state of the stock market to tell you where he believes we are all headed.
Copper Co. Rated 'Strong Buy for All Timeframes' (11/14/2022)
Since copper has just broken out of a multi-month Cup & Handle base, expert Clive Maund reviews four charts of a company he believes you should set your sights on.
UK Co. Buys NARCAN® Nasal Spray Maker (11/14/2022)
Opiant Pharmaceuticals Inc. shares traded 111% higher after the company reported it entered into a definitive agreement to be acquired by Indivior Plc. for US$20.00 per share in cash. Opiant shareholders will also receive contingent value rights that are worth up to an additional US$8.00/share if certain product sales milestones are met.
With late-stage drug candidates and major near-term catalysts, undervalued Aldeyra Therapeutics warrants a Buy to Outperform rating and consideration by potential investors, according to various analysts.
Biologics Co. Doubles Revenue in Q3/22 (11/11/2022)
ADMA Biologics Inc. shares traded 27.5% higher yesterday after the company reported Q3/22 financial results that included a 99% YOY revenue increase. The firm added that it is raising its FY/22 revenue estimates from US$130 million to US$145 million.
Nova Scotia-based nanotech company Meta Materials Inc. reports a major revenue increase just as it signs an agreement to help reduce the cost and weight of batteries for electric vehicles, extend their range, and improve their safety.
Junior Expands Mineralization at Nevada Gold Project (11/10/2022)
NevGold Corp. has released new assays from its inaugural 10,000-meter drill program at its flagship Limousine Butte project in Nevada.
As the prices of oil stocks are running ahead of oil prices, expert Clive Maund reviews the 7-month, 3-year, and 20-year charts of the oil index to tell you where he believes the commodity is headed.
Pharma Co. Trades 200% Higher (11/10/2022)
Merrimack Pharmaceuticals Inc. shares traded 200% higher yesterday to a new 52-week high after the company advised that Ipsen SA reported that in a Phase 3 clinical trial, Onivyde® regimen was shown to significantly improve overall survival in previously untreated patients afflicted with metastatic pancreatic ductal adenocarcinoma.
Communications Co. Continues To Grow Revenue (11/10/2022)
Printing and marketing services company Data Communications Management Corp. continues to report impressive numbers with its third-quarter revenue.
Along with improving its numbers during the quarter, this firm sold its first ultrasound ablation machines in North America, noted a Research Capital Corp. report.
Production Picking Up at Silver Junior's Peru Plant (11/09/2022)
Silver X Mining Corp.'s mill at its flagship mine in Peru has seen eight consecutive months of increased processing on a three-month moving average from last January.
Nine Stocks Expert Says Should Pique Your Interest (11/09/2022)
Expert Clive Maund reviews the 6-month charts of nine companies he believes are worth keeping an eye on.
Clean Nuclear Med Tech With Quantum Blue Sky (11/09/2022)
With MedTech ASP Isotopes hitting NASDAQ tomorrow, expert Penny Queen reviews the company to tell you why she believes it is worth your attention.
Copper Co.'s Assay Results 'Very Positive' (11/08/2022)
In light of Infinitum Copper Corp.'s Phase 1 drill program at the La Adelita copper project being completed, expert Thibaut Lepouttre tells you his view of the results and where he sees the copper company is headed.
Expert Clive Maund reviews silver's 4-month and 1-year charts to tell you why he believes it is a good time to load up on this precious metal.
Several companies on expert Adrian Day's list have either reported quarterly earnings or had other news. In the case of the larger companies, most have already pre-announced production or sales.
Healthcare Firm Offers US$295M for Ophthalmology Co. (11/08/2022)
Shares of Oyster Point Pharma Inc. traded 38.5% higher yesterday after the firm reported it agreed to be acquired by Viatris Inc. for US$11.00 per share along with a contingent value right for a potential additional payment of up to US$2.00 per share.
Drone Co. Sees Record Revenue Jump (11/08/2022)
Volatus Aerospace Corp. has announced record third-quarter revenue, a 238% increase YOY.
The Tipping Point (11/08/2022)
Expert Dr. Jim Jones shares his extensive research on Emerita Resources Corp. to tell you why he believes this is only the tipping point for the company and what catalysts he sees up and coming.
Pharma Co. Signs Global License Deal for Eye Drops (11/08/2022)
Shares of Ocuphire Pharma Inc. traded 20% higher after the ophthalmology-focused biopharmaceutical firm reported it executed a global license agreement with FamyGen Life Sciences Inc. to develop and commercialize its Nyxol® Eye Drops for use in treating mydriasis, presbyopia, and night vision disturbances.
A Most-Beguiling Fork (11/07/2022)
Expert Michael Ballanger believes markets are at a critical juncture, commonly referred to as a "fork in the road." In light of this, he reviews current Fed updates and movements in the gold and silver sectors to tell you where he believes the market is heading.
Expert Clive Maund takes a look at some movements in the precious metals sector with a focus on the gold market to tell you where he believes it is headed.
Pan American and Agnico Team Up for Yamana (11/07/2022)
Expert Adrian Day believes the gold sector is picking up again and reviews two companies attempting to outbid Gold Fields in its proposed takeover of Yamana Gold.
Given the amount of drilling happening at this Spanish project and the new drill data so far, it is likely the new resource estimate will exceed the historical one, noted a Research Capital Corp. report.
Organ Transplant Co.'s Q3 Revenues Rise 378% (11/04/2022)
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million.
Telemedicine Co. Surges on Revenue News (11/04/2022)
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar.
The Fed Has Lots of Room To Move Rates Higher (11/04/2022)
The Fed's mandate is 2% inflation and maximum employment. Expert Ron Struthers believes they have lots of room to soften the job market. Struthers also sees promise with three stocks. Gilat Satellite is growing sales, Callon Petroleum is undervalued, and Zonte Metals has a unique situation.
Arcturus Therapeutics Holdings Inc. shares traded 19% higher yesterday after the firm reported it entered a global partnership with CSL Seqirus to develop and commercialize self-amplifying mRNA vaccines worldwide.
A Haywood Securities analyst initiates coverage on Dolly Varden Silver Corp., saying "now is the right time" for investing in the company.
Solar Co.'s Equipment Sales Rise 74% YOY (11/03/2022)
Shares of turnkey residential solar firm Sunrun Inc. traded 19% higher after the company reported Q3/22 financial results that included a 44% YoY increase in revenue and a 21% gain in its installed customer base.
This firm, with both high-grade silver and gold assets in one project, already has a resource large enough for a mining-processing operation, noted a Haywood Securities report.
Rover Metals Corp., which is pivoting to critical metals and minerals, is looking to a peer’s feasibility study to help prove the viability of the resource at its new project.
Kiniksa Pharmaceuticals Ltd. shares traded 12% higher yesterday after the company reported Q3/22 financial results that included a 720% YoY increase in net revenue attributed to a combination of organic growth and increases in global licensing revenue.
The 'Bear Killer' Does it Again (11/01/2022)
Expert Michael Ballanger reviews recent updates in the stock market to tell you where he believes it is headed and why he thinks October was "The Bear Killer," with countless bear markets ending and bull markets possibly beginning today, November 1, 2022.
With this season's drilling behind it, the Canadian explorer plans to start, by year-end, the next step in advancing its project, noted a Noble Capital Markets report.
Biopharma Co. Trades 39% Higher (11/01/2022)
Actinium Pharmaceuticals Inc. shares traded 39% higher yesterday to a new 52-week high after the firm reported topline data from its Phase 3 SIERRA study of Iomab-B in patients with active relapsed or refractory acute myeloid leukemia. During the pivotal trial, Iomab-B met its primary pre-established endpoint of durable complete remission or dCR of six months post-initial remission following a bone marrow transplant.
The decline in gold prices will not last forever, and we just witnessed a double bottom and now heard Central Banks are buying at a record pace. Newmont mining is expert Ron Struthers' go-to stock when gold prices start to move, and he believes it currently offers great value with an over 5% dividend yield.
The high-grade and mineable widths of this zone will likely improve the economics of the future mining operation in Fiji, noted a ROTH Capital Partners report.
|"MAG's Deer Trail showed long widths of Ag-Au-Cu-Pb-Zn mineralization."|
|"Drill results showed mineral continuity between TLG's two mined pits."|
|"Surface sample results highlight the upside potential at BWCG's Hyder."|
|"The PFS on DEFN's Wicheeda is expected to be completed by Q4/23."|
|"AGN plans to initiate a Phase 2b trial of ifenprodil in chronic cough."|